Prevention of invasive pneumococcal disease among HIV-infected adults in the era of childhood pneumococcal immunization-Reference-Cited by-同舟云学术

Prevention of invasive pneumococcal disease among HIV-infected adults in the era of childhood pneumococcal immunization

Published:2010-09-10 Issue:14 Volume:24 Page:2253-2262
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:

Author:

Cohen Adam L,Harrison Lee H,Farley Monica M,Reingold Arthur L,Hadler James,Schaffner William,Lynfield Ruth,Thomas Ann R,Campsmith Michael,Li Jianmin,Schuchat Anne,Moore Matthew R

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference20 articles.

1. The evidence for using conjugate vaccines to protect HIV-infected children against pneumococcal disease;Bliss;Lancet Infect Dis,2008

2. Estimation of HIV incidence in the United States;Hall;J Am Med Assoc,2008

3. A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection;Klugman;N Engl J Med,2003

4. Changes in invasive Pneumococcal disease among HIV-infected adults living in the era of childhood pneumococcal immunization;Flannery;Ann Intern Med,2006

5. PCR-based quantitation and clonal diversity of the current prevalent invasive serogroup 6 pneumococcal serotype, 6C, in the United States in 1999 and 2006 to 2007;Carvalho Mda;J Clin Microbiol,2009

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pneumococcal Conjugate Vaccine and Pneumococcal Common Protein Vaccines;Plotkin's Vaccines;2023

2. Impact of 13-Valent Pneumococcal Conjugate Vaccine on Invasive Pneumococcal Disease Among Adults With HIV—United States, 2008–2018;JAIDS Journal of Acquired Immune Deficiency Syndromes;2022-05-01

3. Single-Dose 13-Valent Conjugate Pneumococcal Vaccine in People Living With HIV – Immunological Response and Protection;Frontiers in Immunology;2021-12-20

4. Peculiarities of bacterial agents of pneumonia in HIV-infected patients. Preventive measures for pulmonary infections in immunocompromised patients (literature review);Aspirantskiy Vestnik Povolzhiya;2020-05-28

5. Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine in HIV-infected adults in the era of highly active antiretroviral therapy: analysis stratified by CD4 T-cell count;Human Vaccines & Immunotherapeutics;2019-08-23